Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01486030 · ClinicalTrials.gov registry record
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 20
- Enrollment target
NCT01486030 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 20 participants.
The verdict
NCT01486030 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a prospective, single-center study that aims to evaluate the acute and delayed effect of exercise stress testing on the peripheral gene expression (PGE) levels using a predefined gene set established in the Corus CAD (Age/Sex/Gene Expression score - ASGES) test in subject with known obstructive coronary artery disease (CAD) and in control subjects (without known CAD).
Interventions
- DIAGNOSTIC_TEST Corus CAD (ASGES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01486030
The ClinicalTrials.gov registry entry for NCT01486030 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioDx, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corus CAD (ASGES) is the first listed.
NCT01486030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01486030 about?
NCT01486030 is a clinical study titled "Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test". This is a prospective, single-center study that aims to evaluate the acute and delayed effect of exercise stress testing on the peripheral gene expression (PGE) levels using a predefined gene set established in the Corus CAD (Age/Sex/Gene Expression score - ASGES) test in subject with known obstruct...
What is the current status of trial NCT01486030?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-09. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01486030?
The interventions under investigation include: Corus CAD (ASGES) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01486030?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.